Click to go to Neuromab Home Click to go to UC Davis Home  
Home      News      Price List      Catalog      Current Projects      Protocols      Suggestions      Publications      Contact Us
Search Publications :
Search Catalog :
UC Davis/NIH NeuroMab Facility New Project Suggestion Area

The UC Davis/NIH NeuroMab Facility is accepting suggestions as to future NeuroMab targets.

Requestors should supply the UC Davis/NIH NeuroMab Facility with:

  • a scientific justification as to the biological importance of the target molecule, the importance of these reagents to the national neuroscience community, and the availability and suitability of existing polyclonal and/or monoclonal antibodies.
  • a list of reagents (synthetic peptides, fusion proteins, full-length cDNAs for transfection in mammalian cells, samples from knockout mice) that will be made available to the NeuroMab staff to facilitate the development and characterization of these NeuroMabs.
  • detailed information on the expression pattern of the target molecule in mammalian brain. Especially crucial is information on its developmental pattern of expression, and its regional, cellular and subcellular distribution in adult brain. Any information for expression in rat, which is the system used for NeuroMab screening and validation, is especially helpful. Include relevant references if possible.

Submit this information to the UC Davis/NIH NeuroMab Facility here by clicking the 'Submit' button or save your draft to edit/finish/submit in another session. Upon submission, an automatic "Suggestion Submission" email will be sent to neuromab@ucdavis.edu and an automatic "Suggestion Received" receipt with a copy of your submission will be emailed to you. The NeuroMab advisory board, acting in concert with NIH program officials, will then prioritize the request in the NeuroMab queue and you will be contacted once a decision has been made. Upon completion of a project, any resulting NeuroMabs will then be added to the catalog and made freely available to the research community at low cost.  Note that all hybridomas and mAbs developed by the UC Davis/NIH NeuroMab Facility are the property of the Regents of the University of California.

Please note that your session will time out after 20 minutes of inactivity so, in order to prevent losing your work, you are encouraged to consider copying text from another document. If you encounter errors while registering as a website user, submitting a new target suggestion or using our website in other ways, then please contact us and attach a copy of the error message to help us resolve the issue.

NeuroMab Login
Username :
Password :


Not yet a member?
[ Click here to sign up! ]


Forgot your password?
[ Click here to have your password emailed to you ]
© Copyright 2012